News
-
-
REGULATED PRESS RELEASE
Disclosure of transactions in own shares from July 13 to July 17, 2026
-
-
-
PRESS RELEASE
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review
First Berlin Equity Research updates rating and price target for Jaguar Health Inc (ISIN: US47010C8055) to 'Under Review' due to recent restructuring steps and ongoing liquidity concerns, while recognizing positive clinical developments -
PRESS RELEASE
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of April 30, 2026
2CRSi Group reveals monthly voting rights and shares data as of April 30, 2026 under French regulations. The company specializes in designing high-performance, eco-friendly servers for AI applications -
PRESS RELEASE
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of April 30, 2026
2CRSi SA releases monthly info on total voting rights and shares for April 30, 2026. The French company specializes in eco-friendly AI servers and global IT solutions -
REGULATED PRESS RELEASE
Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Imerys publishes the number of outstanding shares and voting rights as of 30 June 2026, in compliance with regulations. The leading supplier of mineral-based specialty solutions focuses on sustainable development and high value-added solutions for various industries -
-
PRESS RELEASE
EQS-Adhoc: edding Aktiengesellschaft: Adjustment of guidance for Financial Year 2026
edding Aktiengesellschaft adjusts 2026 financial guidance due to lower sales expectations and higher restructuring costs. Group sales revenue revised to EUR 138-150 million with EBIT expected at EUR 1-4 million